Thromboprophylaxis with standard- vs. flexible-dose heparin for hospitalized COVID-19 patients: a target trial emulationResearch article Published on 2022-11-012022-10-05 Journal: Journal of clinical epidemiology [Category] 임상, [키워드] 28-day mortality 95% confidence interval Anticoagulants anticoagulation baseline bleeding Coagulopathy COVID-19 COVID-19 diagnosis COVID-19 drug treatment dose eligible Epidemiological methods estimate hazard ratio hospitalized COVID-19 hospitalized COVID-19 patient hospitalized COVID-19 patients intensity intermediate dose laboratory abnormality LMWH Low–molecular weight heparin Major Mortality objective Observational data Patient Result risk setting Spain Standard dose survival target Target trial emulation Thromboprophylaxis thrombosis thrombotic risk Trial [DOI] 10.1016/j.jclinepi.2022.08.006 [Article Type] Research article
Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective studyArticle Published on 2022-10-312022-11-15 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] 95% CI Accuracy acute respiratory syndrome Analysis antibodies antibody Antibody detection assessments Blood capillary blood chemiluminescent immunoassay CLIA coronavirus coronavirus disease COVID-19 COVID-19 disease cut off cut-off Diagnosis diagnosis of COVID-19 diagnostic Efficacy ELISA evaluate facilitate gold standard identify IgM and IgG immunochromatographic assay information intensity Italy Laboratory Lateral lateral flow lateral flow immunoassay Lateral flow test measure NAAT Non-invasive nucleic acid amplification Patient patients performed POC positive Prospective Study provided Quantitative Rapid Rapid diagnostic test RDT SARS-CoV-2 SARS-CoV-2 antibody semi-quantitative sensitivity serological test serology Serology. Severity of disease specificity symptom onset Test the timing venous whole sample [DOI] 10.1186/s12879-022-07786-5 PMC 바로가기
Saliva metabolomic profile of COVID-19 patients associates with disease severityArticle Published on 2022-10-222022-11-15 Journal: Metabolomics [Category] COVID19(2023년), SARS, 바이오마커, 치료기술, [키워드] 5-aminolevulinic acid Asymptomatic Biomarker Biomarkers C-reactive protein cellular change changes changes in Comparisons controls Coronavirus disease 2019 correlated COVID-19 COVID-19 group COVID-19 patient COVID-19 patients D-dimer diagnostic Disease progression disease severity dysregulation early stage expected Infection intensity Level liquid liquid chromatography-mass spectrometry metabolite metabolomic metabolomics Mild moderate molecular non-infected non-severe patients parameter Patient physiological plasma positively correlated profile prognostic prognostic biomarker risk Saliva Saliva. SARS-CoV-2 screened severity significantly sphingosine stages utility were used [DOI] 10.1007/s11306-022-01936-1 PMC 바로가기
Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging VariantsArticle Published on 2022-10-202022-11-15 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 진단, [키워드] Belgium country COVID-19 effort genomic genomic sequencing Genomic surveillance intensity Laboratory Lineage Next-generation sequencing performed Quality control Research SARS-CoV-2 SARS-CoV-2 genome SARS-CoV-2 genomic surveillance Surveillance the SARS-CoV-2 variant variants of concern variants of concern. Year [DOI] 10.3390/v14102301 PMC 바로가기
Optimized parameters for effective SARS-CoV-2 inactivation using UVC-LED at 275 nmArticle Published on 2022-10-052022-11-15 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 치료제, [키워드] Antiviral effect Community contribute coronavirus disease COVID-19 dose effective feature healthcare inactivation intensity investigated irradiation less medications new treatment strategy pandemic parameter Prevent reduce reduction SARS-CoV-2 SARS-COV-2 infection severity Spread temperature Vaccines viral mutation Viral transmission [DOI] 10.1038/s41598-022-20813-4 PMC 바로가기
Exploitation of N-Gene of SARS-CoV-2 to Develop a New Rapid Assay by ASOs@AuNPsArticle Published on 2022-10-042022-11-15 Journal: Analytical Chemistry [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] amplification annealing Antisense oligonucleotide AuNP denaturation detect Detection limit DNA Gold nanoparticle gold standard guanine intensity labeling Modification N-gene New nucleocapsid polymerase chain Rapid Result RNA RNA gene RNA viruses RT-qPCR SARS-CoV-2 simplicity suggested threshold throat swab [DOI] 10.1021/acs.analchem.2c03544 PMC 바로가기
A paper-based optical sensor for the screening of viruses through the cysteine residues of their surface proteins: A proof of concept on the detection of coronavirus infection표면 단백질의 시스테인 잔기를 통한 바이러스 스크리닝을 위한 종이 기반 광학 센서: 코로나바이러스 감염 감지에 대한 개념 증명Article Published on 2022-10-012022-09-11 Journal: Talanta [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus BENZOTHIAZOLE Biothiol cause Chain Reaction clinical study Colorimetric assay complex Concentration coronavirus Coronavirus infection current cysteine cysteine residue Disulfide disulfide bond Filter Paper group Health Human immunodeficiency virus human Papilloma virus immunodeficiency intensity lab lack limit of detection linear relationship logarithm lowest naked eye nasopharyngeal swabs optical pandemic paper Paper based sensor papilloma pathology Patient pink color polymerase chain polymerase chain reaction proof proof of concept Protein Proteins qRT-PCR Rapid reduced required reverse transcription reverse transcription polymerase chain reaction S1 protein Saliva SARS-CoV-2 SARS-CoV-2. screening method severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 specimens Spike protein subunit sulfhydryl the S1 protein time-consuming virus virus viruses [DOI] 10.1016/j.talanta.2022.123630 PMC 바로가기 [Article Type] Article
Cytotoxic lesions of the corpus callosum after COVID-19 vaccinationArticle Published on 2022-10-012022-11-15 Journal: Neuroradiology [Category] COVID19(2023년), SARS, 진단, [키워드] amnesia Antibody test Biochemistry blood cell count Brain callosum cerebrospinal fluid Coronavirus disease 2019 corpus COVID-19 COVID-19 mRNA Vaccination COVID-19 mRNA vaccine COVID-19 vaccination cytotoxic Cytotoxic lesions of the corpus callosum Depression disease distal Fever headache healthy intensity intravenous methylprednisolone inversion lesion limbs Mild encephalitis/encephalopathy with reversible splenial lesion. MRI mRNA nausea neurological Neurological symptom Patient PCR test reported SARS-CoV-2 splenial Symptom visual disturbance [DOI] 10.1007/s00234-022-03010-y PMC 바로가기
A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjectsArticle Published on 2022-09-292022-11-15 Journal: PLoS ONE [Category] SARS, 변종, 진단, [키워드] antibodies antibody Antigen applied Characteristics Collecting COVID-19 defined determine Dilution dilutions dose doses help humoral Humoral immunity immune response Infection information intensity linear long-lasting MONITOR Pfizer Prevent profile protective immunity quantification quantitative assay RBD reactivity Reinfection Sample SARS-CoV-2 SARS-CoV-2 antigens serological serology test serum sample subject two group vaccination Vaccination strategies Vaccine variant Viral antigen was used were used [DOI] 10.1371/journal.pone.0274553 PMC 바로가기
EQUIP emergency: can interventions to reduce racism, discrimination and stigma in EDs improve outcomes?Clinical Trial Published on 2022-09-022022-10-05 Journal: BMC health services research [Category] 임상, [키워드] activities activity age Analysis Canada Care clinical collected Community COVID 19 death Department dimension discrimination Emergency Emergency Departments Epidemic equity group Health Health disparities health equity Health inequity IMPROVE Indigenous intensity Intervention Intervention research longitudinal mounted Multiple regression overdose pandemic Patient post-intervention presenting promote question racism reduce reduction Research resource robust shown sick significant decrease significantly Stigma Stigma. supported survey tested Throughout the study trauma was tested worsening [DOI] 10.1186/s12913-022-08475-4 PMC 바로가기 [Article Type] Clinical Trial